Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Sep 15, 2025
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Award
Common Stock, $.0001 par value
2025-09-11+250,000→ 271,421 total - Tax Payment
Common Stock, $.0001 par value
2025-09-11$2.32/sh−4,111$9,538→ 21,421 total
Footnotes (3)
- [F1]The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- [F2]Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
- [F3]Includes shares of common stock underlying unvested restricted stock units.